BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 231 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,573,155 | +12.5% | 77,880 | -7.4% | 0.01% | 0.0% |
| Q4 2023 | $2,288,140 | -10.5% | 84,061 | -20.9% | 0.01% | -11.1% |
| Q3 2023 | $2,555,769 | +6.6% | 106,269 | +41.5% | 0.01% | +12.5% |
| Q2 2023 | $2,398,071 | +37.7% | 75,104 | +32.1% | 0.01% | +33.3% |
| Q1 2023 | $1,741,421 | -12.6% | 56,872 | +11.6% | 0.01% | -25.0% |
| Q4 2022 | $1,993,437 | +6.4% | 50,970 | +29.5% | 0.01% | 0.0% |
| Q3 2022 | $1,874,000 | -25.0% | 39,347 | -39.0% | 0.01% | -11.1% |
| Q2 2022 | $2,499,000 | +12.4% | 64,556 | +66.4% | 0.01% | +28.6% |
| Q1 2022 | $2,223,000 | -10.9% | 38,796 | +23.9% | 0.01% | 0.0% |
| Q4 2021 | $2,495,000 | +6.5% | 31,308 | +16.3% | 0.01% | 0.0% |
| Q3 2021 | $2,343,000 | -46.4% | 26,926 | -20.7% | 0.01% | -50.0% |
| Q2 2021 | $4,368,000 | +146.5% | 33,938 | +53.3% | 0.01% | +133.3% |
| Q1 2021 | $1,772,000 | – | 22,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
| HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
| Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
| ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
| Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
| Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
| Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.50% |
| Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |